Join
Live feed
·
INSIDERFilingvia Quantisnow
Cytokinetics Incorporated logo

Director Harrington Robert Arthur was granted 197 shares, increasing direct ownership by 1% to 18,739 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CYTK (Cytokinetics Incorporated) and more on Quantisnow.

Director Harrington Robert Arthur was granted 197 shares, increasing direct ownership by 1% to 18,739 units (SEC Form 4) | Quantisnow